Hybrid Intracavitary-Interstitial brachytherapy in a case of nasal vestibule cancer penetrating the hard palate

Naoya Murakami; Go Omura; Wakako Yatsuoka; Hiroyuki Okamoto; Seiichi Yoshimoto; Takao Ueno; Jun Itami

doi:10.1259/bjrcr.20200178

Hybrid Intracavitary-Interstitial brachytherapy in a case of nasal vestibule cancer penetrating the hard palate

BJR Case Rep. 2021 Mar 25;7(4):20200178. doi: 10.1259/bjrcr.20200178. eCollection 2021 Jul 16.

Authors

Naoya Murakami¹, Go Omura², Wakako Yatsuoka³, Hiroyuki Okamoto⁴, Seiichi Yoshimoto², Takao Ueno³, Jun Itami

Affiliations

¹ Department of Radiation Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.
² Department of Head and Neck Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.
³ Dental Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.
⁴ Department of Medical Physics, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo, Japan.

Abstract

Because of its rarity, no standard therapy exists for localized squamous cell carcinoma of the nasal vestibule. Interstitial brachytherapy (ISBT) is reported to be a preferable treatment modality of choice for early-stage localized nasal vestibule cancer. In this report, a nasal vestibule cancer with hard palate invasion (T3) was treated by definitive radiation therapy. Because it was considered to be difficult to cover the entire target volume only by ISBT, a hybrid of intracavitary (dental mold-based) and ISBT was applied to the patient following external beam radiation therapy.

Publication types

Case Reports